Vertex Pharmaceuticals (NASDAQ:VRTX)

Top Analyst Upgrades and Downgrades: AK Steel, Altice USA, Biogen, Caterpillar, Gilead, Oracle and Many More

Stocks have recently hit all-time highs again, but the stock indexes seem to have gone sideways in recent days and they were looking for direction on a slow news Friday. ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Analog Devices, Camping World, Ciena, Deere, RSP Permian, Ulta Beauty, Yum China and Many More

Stocks were indicated to open higher on Friday at a record. This is after President Trump exited the Paris climate accord and after a weaker than expected nonfarm payrolls report. ...
Read Full Story »

Wednesday’s Biggest Winners and Losers in the S&P 500

May 31, 2017: The S&P 500 closed lower on the day, down 0.05% at 2,411.73. Separately the DJIA closed down 0.11% at 21,005.93. The Nasdaq also closed down 0.08% at ...
Read Full Story »

Hot Recent Tech IPO Highlights Jefferies Top Growth Stocks to Buy

The first quarter ended Friday, and despite the overall outstanding gains for the quarter, the gains were all in January and February as March was essentially flat. With earnings reporting starting ...
Read Full Story »

The 5 Best Performing S&P 500 Stocks for Q1

Between the November election and the end of 2016, the S&P 500 index gained 4.6%. Since the beginning of 2017, the index has added another 5.53%. The so-called Trump bump ...
Read Full Story »

Wednesday’s Biggest Winners and Losers in the S&P 500

March 29, 2017: The S&P 500 closed higher on the day, up 0.11 % and 2.56 points to 2,361.14. Separately the DJIA closed down 0.20% on the day at 20,659.39, ...
Read Full Story »

Why This Key Analyst Has a Mixed View of Vertex’s Win

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) shares jumped after the firm released results from two Phase 3 studies in the treatment of cystic fibrosis in ages 12 and older. Ultimately they ...
Read Full Story »

Tuesday’s Top Biopharma Movers

A few biopharma stocks made massive runs on Wednesday morning as the result of clinical trial results and earnings. Although not all these moves were positive, the overall sentiment was ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Boeing, Capital One, CenturyLink, Morgan Stanley, NRG Energy, Vertex and Many More

Stocks were indicated marginally higher on Wednesday, after Tuesday finally broke a multiyear record for down days in the markets. The Dow Jones Industrial Average is still down less than ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Adobe, Barclays, Dean Foods, Netflix, Simon Property, Snap, Vertex and More

Stocks were indicated higher yet again on Friday, even knowing that many market participants are going to sneak out at lunch for St. Patrick's Day revelry. The Dow is still ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Mobileye, Occidental, Oracle, Disney, Wal-Mart and Many More

Stocks were indicated to open lower on Tuesday while a massive blizzard is disrupting the northeastern United States. All eyes remain on the Federal Open Market Committee (FOMC) ahead of ...
Read Full Story »

Monday’s Top Health Care Stocks Screaming Higher

It seems that markets are slowing down and taking a step back after hitting new highs in what has been known as the Trump rally. Although Monday might be slow ...
Read Full Story »
automatic inspection machine

Baird Has 4 Red-Hot Biotechs to Buy for 2017 With Huge Upside Potential

Needless to say, the past two years have been rough on biotech. So rough in fact, that a basket of the largest capitalization stocks now trade with a price-to-earnings growth ...
Read Full Story »
Test tubes

Jefferies Has 5 Top Biotech Stocks to Buy for 2017

Needless to say, the past two years have been rough on biotech. So rough in fact, that a basket of the largest capitalization stocks now trades with a price-to-earnings growth ...
Read Full Story »
choose happiness

RBC Likes Large Cap Biotech Leaders for 2017

After a very poor 2016 for the biotechs, some on Wall Street are beginning to think that the light at the end of the tunnel may not be another train ...
Read Full Story »